Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Read the details of recent consultations, submissions and decisions at the TGA Consultation hub.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (72)
- Therapeutic goods regulation (18)
- Over the counter (OTC) medicines (14)
- Prescription medicines (13)
- Legislation (10)
- Complementary medicines (9)
- Listed medicines (8)
- Non-prescription medicines (8)
- Advisory bodies and committees (7)
- Manufacturing (6)
- Labelling and packaging (5)
- Advertising (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Medical devices safety (3)
- Medicines safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Shortages (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
We are experiencing technical issues with the date sort order of our Consultations list.
Our open consultations are appearing at the end of the list.
Please use the filters or search function to help find relevant consultations.
Results for
"[search-keyword]"
Search
238 result(s) found, displaying 76 to 100
-
Closed onConsultationOutcomes of the consultation and submissions received have now been published
-
Consultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Triptans
Closed onConsultationOutcomes of the consultation and submissions received have now been published -
Closed onConsultationOutcomes of the consultation and submissions received have now been published
-
Closed onConsultationThe outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published
-
Closed onConsultationThe public consultation for the Proposed refinements to the requirements for medical device patient information materials.
-
Closed onConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 17-18 March 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and Advisory Committee on Chemicals Scheduling (ACCS).
-
Closed onConsultationSubmissions published and summarised as part of a consultation on medical devices that are substances for introduction into the body.
-
Closed onConsultationThe closing date has been extended and now closes on 14 July
-
Closed onConsultationThe TGA is seeking feedback on a proposal to remake some of the legislative instruments relating to human cell and tissue (HCT) products (including blood and blood components), which sunset in October 2021. Closing date: 11 July 2021
-
Closed onConsultationThe outcomes of the public consultation into proposed improvements to the Therapeutic Goods Advertising Code have been published.
-
Closed onConsultationProposed amendments to the Poisons Standard. Closing date: 4 June 2021
-
Closed onConsultationProposed amendments to the Poisons Standard, including substances in hand sanitisers. Closing date: 27 May 2021
-
Closed onConsultationProposed amendments to the Poisons Standard. Closing date: 27 May 2021
-
Closed onConsultationProposed amendments to the Poisons Standard. Closing date: 27 May 2021
-
Closed onConsultationThe closing date for this consultation has been extended until 27 May 2021
-
Closed onConsultationOutcomes of the consultation and submissions received have now been published
-
Closed onConsultationOutcomes of the consultation and submissions received have now been published
-
Closed onConsultationThe TGA is seeking feedback on proposed advisory statements for OTC medicines containing methyl salicylate for inclusion in RASML. Closing date: 18 May 2021
-
Closed onConsultationOutcomes of the consultation and submissions received have now been published
-
Closed onConsultationView the outcomes of public consultation on building a more robust medicine supply
-
Closed onConsultationThe IMDRF working group is seeking comments from interested parties on the proposed guidance document. Closing date: 19 April 2021
-
Closed onConsultationTGA is seeking comments on whether the Australian medical device regulatory framework should be aligned to the EU framework for medical devices containing nanomaterials. Closing date: 9 April 2021
-
Closed onConsultationThis consultation is to obtain feedback in relation to proposals to provide clarity on residual claims for disinfectants. Closing date: 26 March 2021
-
Closed onConsultationTGA is consulting on a proposed standard for vaporiser nicotine products (e.g. nicotine e-liquids). Closing date: 31 March 2021
-
Closed onConsultationThe closing date has been extended until 30 March 2021.
This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/consultation